The FDA granted accelerated approval to subcutaneous amivantamab and hyaluronidase (Rybrevant Faspro) for the treatment of adults with recurrent or metastatic head and neck squamous cell carcinoma.

Russell Brand, an ally of Health Secretary Robert F. Kennedy Jr. and the Make America Healthy Again (MAHA) movement, was ...

Attendees at the American Public Health Association's (APHA) annual meeting gathered to watch the midterm election results ...

An infant in southwestern Wisconsin has died after contracting measles, the state's first death from the disease in 36 years, state officials announced Thursday. The Wisconsin Department of Health ...

In the DUOTAP trial, routine postdilation largely corrected any Sapien device asymmetry, with transcatheter heart valve (THV) ...

Preminger said that facelifts aren't particularly painful, but innovation in the plastic surgery space still makes for better ...

More than 264 million people globally had gallbladder and biliary diseases such as cholelithiasis, cholecystitis, or ...

Roughly 20% to 40% of individuals with IgA nephropathy will develop end-stage kidney disease within 20 years of diagnosis and ...

Democrats' decisive sweep of the U.S. House and Senate in Tuesday's elections will reshape the direction of federal health ...